Compounds > nitrendipine
Page last updated: 2024-11-01

nitrendipine and Anterior Circulation Transient Ischemic Attack

nitrendipine has been researched along with Anterior Circulation Transient Ischemic Attack in 4 studies

Nitrendipine: A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
nitrendipine : A dihydropyridine that is 1,4-dihydropyridine substituted by methyl groups at positions 2 and 6, a 3-nitrophenyl group at position 4, a ethoxycarbonyl group at position 3 and a methoxycarbonyl group at position 5. It is a calcium-channel blocker used in the treatment of hypertension.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dowlatshahi, D1
Hill, MD2
Boulanger, JM1
Strauss, MH1
Verma, S1
Owen, A1

Trials

3 trials available for nitrendipine and Anterior Circulation Transient Ischemic Attack

ArticleYear
Morbidity and mortality after stroke--eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES).
    Stroke, 2006, Volume: 37, Issue:2

    Topics: Acrylates; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Data Interpretation, S

2006
MOSES raises questions.
    Stroke, 2006, Volume: 37, Issue:2

    Topics: Acrylates; Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Data Interpretation, Stati

2006
MOSES: superiority or noninferiority?
    Stroke, 2006, Volume: 37, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Cardiovascular Diseases; Cerebrovascular Disorders; Clinica

2006

Other Studies

1 other study available for nitrendipine and Anterior Circulation Transient Ischemic Attack

ArticleYear
Angiotensin receptor blockers and secondary stroke prevention: the MOSES study.
    Expert review of cardiovascular therapy, 2009, Volume: 7, Issue:5

    Topics: Acrylates; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors;

2009